Preconditions for the development of neuroethics in clinical practice of Yakutia
https://doi.org/10.25789/YMJ.2024.87.23
Abstract
In recent decades, a new interdisciplinary field of research in the field of neuroscience neuroethics has been formed. The article is aimed at discussing the possibility of introducing neuroethics into clinical practice, since complicated complex methods are used for examination, treatment, rehabilitation and prevention of neuropathology, which differ from traditional ones. At the stages of treatment, rehabilitation and prevention of neurodegenerative diseases, ethical questions and dilemmas occur that force health care professionals to make decisions by reflecting on the moral problems arising in the process of work.
About the Author
S. K. Kononova
YSC CMP
Russian Federation
Russian Federation
Kononova Sardana Kononovna – PhD in Biology, leading researcher of YSC CMP
References
1. Myotonic dystrophy in RS(Y): population features and approaches in DNA diagnostics /sukhomyasova A.L. [et al.] Yakut Medical Journal. 2003. No.2. P.12-17.
2. Organizational, methodological and ethi-cal problems of DNA diagnostics of monogenic diseases in the practice of medical and genetic counseling in Yakutia / Kononova S.K. [et al.] Medical genetics.2006. P.14-17.
3. The prevalence of spinocerebellar ataxia type 1 in Yakutia: the current state / Fedorov A. I. [et al.] Medical genetics. 2020. Vol. 19, No. 7(216). P. 29-30. DOI: 10.25557/2073-7998.2020.07.29-30.
4. Comparison of anxiety levels in patients with monogenic hereditary diseases of the nervous system / Gurinova E.E. [et al.] Yakut Medical Journal. 2009. No. 2(26). P.80-83
5. Aoki Y. Shared decision making for adults with severe mental illness: A concept analysis. Jpn J Nurs Sci. 2020;17(4):e12365. doi: 10.1111/jjns.12365.
6. Aoki Y, Yaju Y, Utsumi T, Sanyaolu L [et al] Shared decision-making interventions for people with mental health conditions. Cochrane Database Syst Rev. 2022;11(11):CD007297. doi: 10.1002/14651858.CD007297.pub3.
7. Antoniou R, Hausermann T, Sideman AB [et al] Moral reasoning through the eyes of persons with behavioral variant frontotemporal dementia. Front Neurol. 2023 Jul 10;14:1197213. doi: 10.3389/fneur.2023.1197213.
8. Benavides-Piccione R, Blazquez-Llorca L, Kastanauskaite A [et al] Key morphological features of human pyramidal neurons. Cereb Cortex. 2024; 34(5):bhae180. doi: 10.1093/cercor/bhae180.
9. Byrjalsen A, Tybjærg-Hansen A, Juul K [et al ] Actionability and familial uptake following opportunistic genomic screening in a pediatric cancer cohort. Eur J Hum Genet. 2024 ;32(7):846-857. doi: 10.1038/s41431-024-01618-7.
10. Budić M, Galjak M, Rakić V. What drives public attitudes towards moral bioenhancement and why it matters: an exploratory study. BMC Med Ethics. 2021; 22(1):163. doi: 10.1186/s12910-021-00732-1
11. Chiong W. Insiders and Outsiders: Lessons for Neuroethics from the History of Bioethics. AJOB Neurosci. 2020;11(3):155-166. doi: 10.1080/21507740.2020.1778118.
12. Drew DS, Muhammed K, Baig F [et al] Dopamine and reward hypersensitivity in Parkinson's disease with impulse control disorder. Brain. 2020; 143(8):2502-2518. doi: 10.1093/brain/awaa198.
13. Farahany N, Ramos KM. Neuroethics: Fostering Collaborations to Enable Neuroscientific Discovery. AJOB Neurosci. 2020;11(3):148-154. doi: 10.1080/21507740.2020.1778117.
14. Fernández E, Alfaro A, Soto-Sánchez C [et al] Visual percepts evoked with an intracortical 96-channel microelectrode array inserted in human occipital cortex. J Clin Invest. 2021;131(23):e151331. doi: 10.1172/JCI151331.
15. Gidon A, Zolnik TA, Fidzinski P [et al] Dendritic action potentials and computation in human layer 2/3 cortical neurons. Science. 2020; 367(6473):83-87. doi: 10.1126/science.aax6239.
16. Illes J, Bird SJ. Neuroethics: a modern context for ethics in neuroscience. Trends Neurosci. 2006; 29(9):511-7. doi: 10.1016/j.tins.2006.07.002.
17. Lovell K, Bee P, Brooks H [et al] Embedding shared decision-making in the care of patients with severe and enduring mental health problems: The EQUIP pragmatic cluster randomised trial. PLoS One. 2018;13(8):e0201533. doi: 10.1371/journal.pone.0201533.
18. Levy N, Douglas T, Kahane G, Terbeck S, Cowen PJ, Hewstone M, Savulescu J. Are You Morally Modified?: The Moral Effects of Widely Used Pharmaceuticals. Philos Psychiatr Psychol. 2014;21(2):111-125. doi: 10.1353/ppp.2014.0023.
19. LoCastro M, Jensen-Battaglia M, Sanapala C [et al] Exploring the role of the oncologist in promoting shared decision making during treatment planning for older adults with acute myeloid leukemia. J Geriatr Oncol. 2024;15(5):101793. doi: 10.1016/j.jgo.2024.101793.
20. McDonald PJ. It Is Time to Expand the Scope and Reach of Neuroethics. AJOB Neurosci. 2019 Jul-Sep;10(3):128-129. doi: 10.1080/21507740.2019.1632968.
21. Niranjan SJ, Wallace A, Williams BR [et al] Trust but Verify: Exploring the Role of Treatment-Related Information and Patient-Physician Trust in Shared Decision Making Among Patients with Metastatic Breast Cancer. J Cancer Educ. 2020;35(5):885-892. doi: 10.1007/s13187-019-01538-x.
22. Protheroe J, Brooks H, Chew-Graham C [et al] 'Permission to participate?' A qualitative study of participation in patients from differing socio-economic backgrounds. J Health Psychol. 2013;18(8):1046-55. doi: 10.1177/1359105312459876.
23. Ramos KM, Grady C, Greely HT [et al] The NIH BRAIN Initiative: Integrating Neuroethics and Neuroscience. Neuron. 2019 ;101(3):394-398. doi: 10.1016/j.neuron.2019.01.024.
24. Sandman L, Munthe C. Shared decision-making and patient autonomy. Theor Med Bioeth. 2009;30(4):289-310. doi: 10.1007/s11017-009-9114-4
25. Schermer MHN, Richard E. On the reconceptualization of Alzheimer’s disease. Bioethics. 2019;33:138–145. https://doi.org/10.1111/bioe.12516
26. Schön UK, Grim K, Wallin L [et al] Psychiatric service staff perceptions of implementing a shared decision-making tool: a process evaluation study. Int J Qual Stud Health Well-being. 2018;13(1):1421352. doi: 10.1080/17482631.2017.1421352.
27. Stacey D, Lewis KB, Smith M [et al] Decision aids for people facing health treatment or screening decisions. Cochrane Database Syst Rev. 2024; 1(1):CD001431. doi: 10.1002/14651858.CD001431.pub6.
28. Soileau LG, Talbot NC, Storey NR [et al] Impulse control disorders in Parkinson's disease patients treated with pramipexole and ropinirole: a systematic review and meta-analysis. Neurol Sci. 2024 Apr;45(4):1399-1408. doi: 10.1007/s10072-023-07254-1
29. Tolchin B, Conwit R, Epstein LG, Russell JA; Ethics, Law, and Humanities Committee, a joint committee of the American Academy of Neurology, American Neurological Association, and Child Neurology Society. AAN position statement: Ethical issues in clinical research in neurology. Neurology. 2020;94(15):661-669. doi: 10.1212/WNL.0000000000009241.
30. Tam NT, Huy NT, Thoa le TB [et al] Participants' understanding of informed consent in clinical trials over three decades: systematic review and meta-analysis. Bull World Health Organ. 2015;93(3):186-98H. doi: 10.2471/BLT.14.141390.
31. Tate CE, Mami G, McNulty M [et al] Evaluation of a Novel Hospice-Specific Patient Decision Aid. Am J Hosp Palliat Care. 2024 ; 41(4):414-423. doi: 10.1177/10499091231190776.
32. Young MJ, Bernat JL. Emerging Subspecialties in Neurology: Neuroethics: An Emerging Career Path in Neurology. Neurology. 2022; 98(12):505-508. doi: 10.1212/WNL.0000000000200054.
33. Zulman DM, Haverfield MC, Shaw JG [et al] Practices to Foster Physician Presence and Connection With Patients in the Clinical Encounter. JAMA. 2020;323(1):70-81. doi: 10.1001/jama.2019.19003.
Review
For citations:
Kononova S.K. Preconditions for the development of neuroethics in clinical practice of Yakutia. Yakut Medical Journal. 2024;(3):113-116. https://doi.org/10.25789/YMJ.2024.87.23
Views:
19
Email this article 